InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the full record of transactions filed by Tan Kevin, 首席财务官. Insider active across 2 companies, notably Selecta Biosciences INC. In total, 9 disclosures have been recorded. Split: 1 buy · 1 sell. Total volume traded: €94k. Activity tracked since 2 December 2021. The latest transaction was filed on 4 February 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 条申报中的 9 条
Tan Kevin is Directeur Financier. He has 9 filings in total. Among the 9 recent filings tracked, they cover the period from 2021-12-06 to 2026-02-18, with 13363 in purchases and 80594 in sales, and the most frequent transaction nature is option exercise. The recent activity concerns Solid Biosciences Inc. and Selecta Biosciences INC.